Retrospective, single center study of natalizumab in patients with multiple sclerosis in real-world clinical practice
Latest Information Update: 28 Feb 2023
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
Most Recent Events
- 28 Feb 2023 New trial record
- 01 Feb 2023 Results published in the Multiple Sclerosis Journal